Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.24
+0.20 (0.55%)
At close: Aug 6, 2026, 4:00 PM EDT
35.60
-0.64 (-1.76%)
After-hours: Aug 6, 2026, 7:22 PM EDT

IDEAYA Biosciences Revenue

IDEAYA Biosciences had revenue of $8.86M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $234.13M, up 3,244.67% year-over-year. In the year 2025, IDEAYA Biosciences had annual revenue of $218.71M with 3,024.43% growth.

Revenue (ttm)
$234.13M
Revenue Growth
+3,244.67%
P/S Ratio
14.94
Revenue / Employee
$1,614,669
Employees
145
Market Cap
3.50B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025218.71M211.71M3,024.43%
Dec 31, 20247.00M-16.39M-70.07%
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 202019.54M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Legend Biotech1.14B
Telix Pharmaceuticals803.79M
Arcutis Biotherapeutics415.62M
Arcus Biosciences236.00M
Alumis8.40M
NewAmsterdam Pharma Company7.12M
Celldex Therapeutics865.00K
Revenue Rankings

IDYA News

More News